IP Delivers

The U.S. Chamber of Commerce’s Global Intellectual Property Center interviewed biotechnology company CEOs and Senior Executives from around the world at the 2011 BIO International Convention about the importance of their patents to their business. Here is what they said.

Maurice Wagner - Debiopharm Group


Matias Vial Valdes - Cells for Cells
Leading in Chile in Stem Cell Development

Gabor Heltovics - NanGenex Inc.
Budapest, Hungary
Transforming Undruggable Medicinal Compounds

Francois Curtin - GeNeuro SA
Geneva, Switzerland
Treating MS Through Innovation

Steve Fabijanski – Agrisoma
Reducing Dependency on Petroleum

Pierre-Henri Benhamou, DBV Technologies
Revolutionizing Treatments for Peanut Allergies